Actor
Nagi Bioscience SA
Introduces the first Organism-on-Chip technology, which combines the use of a simple yet complete organism for in vivo testing – the tiny worm “Caenorhabditis elegans” – with the first technological platform for its fully automated in vitro handling, culture and analysis. Unprecedented possibilities are now open, for a wide range of applications.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.2 R&D Services
1.27 Drug Discovery & Delivery
1.5 Medical Technology
1.52 Diagnostic & In-Vitro Device
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Endocrine & Metabolic, Gastroenterology, Immunology & Allergy, Toxicology
Main sector
Medtech
Contact
EPFL Innovation Park, Building M
1025 Saint-Sulpice / VD